Core Management

项目负责人/主要研究者（Bell，托马斯，J）： 项目摘要 人体组织和器官研究资源（HTORR）是国家疾病研究中心的一个部门。 交换（NDRI），一个非营利性的NIH资助的组织，其使命是提供生物医学 研究社区与人体组织进行研究。对人类生物标本的要求继续 随着科学问题的复杂性和研究人员所期望的实验方法的发展， 去追求为了满足这一要求，HTORR采用了项目特定的方法和多样化的组织网络 来源研究中心（TSS），为研究者提供获得广泛的正常和病变 人类生物标本进行研究HTORR的专业知识涉及五管齐下的方法来创建一个 可靠的研究资源，以满足这一迫切需要的研究人员。HTORR提供：1）专家客户 为调查人员提供全天候服务和支持，2）通过机会为调查人员提供面向解决方案的方法， 为每个项目制定项目特定的协议，3）获得各种各样的人类生物标本， 所有身体系统，4）通过多个平台进行持续的外展工作，以提高对资源的认识，以及 5)关于捐赠人体组织用于研究的行业最佳做法和标准。执行 该计划的实施将确保高质量的不间断服务，以及注释正常和患病的人 从已建立的组织来源地点网络向研究者提供生物标本， 为生物医学研究界制定和实施创新的大规模举措。 OMB编号0925-0001/0002（修订版03/2020批准至02/28/2023）页码继续格式页码

Program Director/Principal Investigator (Bell, Thomas, J): Project Summary The Human Tissue and Organ Research Resource (HTORR) is a division of the National Disease Research Interchange (NDRI), a not-for-profit NIH-funded organization whose mission is to provide the biomedical research community with human tissues for research. The requirements for human biospecimens continue to evolve in tandem with complexity of scientific questions and experimental methodologies that investigators desire to pursue. To meet this requirement, HTORR utilizes a project-specific approach and a diverse network of tissue source sites (TSS) to provide investigators with the opportunity to obtain a broad range of normal and diseased human biospecimens for their studies. HTORR’s expertise involves a five-pronged approach to creating a reliable research resource to meet this emergent need for investigators. HTORR provides: 1) expert customer service and 24/7 support for investigators, 2) a solution-oriented approach for investigators via the opportunity to develop project-specific protocols for each project, 3) access to diverse range of human biospecimens from all body systems, 4) ongoing outreach efforts via multiple platforms to increase awareness of the resource, and 5) industry best practices and standards regarding the donation of human tissue for research. Implementation of this plan will ensure uninterrupted service of high quality, well annotated normal and diseased human biospecimens to investigators from an established network of tissue source sites, in concert with the development and implementation of innovative, large scale initiatives for the biomedical research community. OMB No. 0925-0001/0002 (Rev. 03/2020 Approved Through 02/28/2023) Page Continuation Format Page